2015 Analysis of Transfusion Diagnostic Technologies, and Strategic Profiles of Leading Suppliers

January 2015 | 114 pages | ID: 2BCD3F4AA6EEN
Venture Planning Group

Abstracts

This 114-page report provides assessments of such technologies as molecular diagnostics, monoclonal and polyclonal antibodies, immunoassays, microtitration plates, IT, lasers, synthetic red cell substitutes, genetically engineered blood components, blood preservation, autologous blood transfusion/freezing and their potential applications for transfusion diagnostic. The report also presents strategic assessments of current and emerging suppliers of transfusion diagnostic products, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.

Contains 114 pages

Contents

Current and Emerging Technologies

Molecular Diagnostics

a. Overview
b. NAT

Monoclonal and Polyclonal Antibodies Immunoassays

a. Technological Principle
b. Chemiluminescence
c. Enzyme Immunoassays (EIA)
  Overview
  ELISA
  EMIT
  Electrochemical
d. Radioimmunoassays (RIA)
e. Immunoprecipitation
f. Affinity Chromatography
Microtitration Plates
IT and Automation
Lasers
Robotics
Synthetic Red Cell Substitutes
Genetically Engineered Blood Components
a. Albumin
b. Factor VIII
c. Alpha- 2 Antiplasmin
d. Antithrombin III
e. Factor IX
f. Von Willebrand's Factor
g. Fibrinogen
h. t- PA
Blood Preservation
Autologous Blood Transfusion/Freezing

Competitive Profiles

Abbott
Beckman Coulter/Danaher
Becton Dickinson
Biokit
BioMerieux
BioRad
Diagast
DiaSorin
Fujirebio
GenProbe
Grifols
Immucor
Innogenetics
OrthoClinical Diagnostics
Orchid CellMark
Novartis Diagnostics
Proteome Sciences
Roche
Siemens
Tecan